Flourish Research, a multi-site clinical trials company based in Apex, has acquired a California clinical research facility.

Kinvard Bio has been formed through a licensing agreement with Harvard University. Kineticos is licensing research from the lab of Andy Myers, a professor in Harvard’s Department of Chemistry and ...

Laura Rowley, Ph.D., vice president of the Life Sciences Economic Development group at the North Carolina Biotechnology ...

From 2019-2023, North Carolina increased the number of life sciences business establishments by 43%. To learn more in the TEConomy 2024 report, click here.

Monroe Biomedical Research (MBR), a dedicated clinical trial site, is growing its footprint to enhance early-phase clinical trials and attract more research opportunities to North Carolina.

Cosette Pharmaceuticals, based in Bridgewater, N.J., with a pharmaceutical production plant in Lincolnton, N.C., will acquire ...

That message is abundantly clear in the newly published analysis, "Evidence & Opportunity 2022: Impact of Life Sciences in NC," which documents why North Carolina continues to garner global admiration ...

Durham-based Locus Biosciences has received $23.9 million in funding from the Biomedical Advanced Research and Development Authority (BARDA) to begin a blinded, placebo-controlled clinical trial of ...